Targeting monocytes/macrophages in the treatment of rheumatoid arthritis.

Abstract

Biotherapies have revolutionized the treatment of RA. However, much work is needed to understand all the mechanisms of these biotherapies, and alternatives are needed to circumvent adverse effects and the high cost of these long-lasting treatments. In this article we outline some of the approaches we have used to target monocytes/macrophages as major components of inflammation and bone homeostasis. We also discuss how anti-TNF-α antibodies target monocytes/macrophages in the complex mechanisms contributing to inhibition of inflammation.

DOI: 10.1093/rheumatology/kes304

3 Figures and Tables

020040020132014201520162017
Citations per Year

542 Citations

Semantic Scholar estimates that this publication has received between 172 and 1,259 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Davignon2013TargetingMI, title={Targeting monocytes/macrophages in the treatment of rheumatoid arthritis.}, author={Jean-Luc Davignon and Myriam Hayder and Michel Baron and Jean-Fr{\'e}d{\'e}ric Boyer and Arnaud Constantin and Florence Apparailly and R{\'e}my Poupot and Alain Cantagrel}, journal={Rheumatology}, year={2013}, volume={52 4}, pages={590-8} }